Enanta Pharmaceuticals, Inc. (ENTA)
14.64
+0.46
(+3.24%)
USD |
NASDAQ |
Dec 09, 16:00
14.62
-0.02
(-0.14%)
After-Hours: 20:00
Enanta Pharmaceuticals EPS Diluted (Quarterly): -0.8746 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
| NanoViricides, Inc. | -0.1045 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.70M |
| Revenue (Quarterly) | 15.12M |
| Total Expenses (Quarterly) | 33.82M |
| Enterprise Value | 434.74M |
| Gross Profit Margin (Quarterly) | 91.51% |
| Profit Margin (Quarterly) | -123.6% |
| Earnings Yield | -26.22% |
| Normalized Earnings Yield | -26.22 |